| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0035685> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0042736> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0042774> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0087071> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C0596263> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C1720833> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32805774_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, Japan.\', \'GF Mille Co., Ltd., Gifu University, Gifu, Japan.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Furuichi_Yasuhiro> <https://research.tib.eu/covid-19/entity/Machitani_Mitsuhiro> <https://research.tib.eu/covid-19/entity/Masutomi_Kenkichi> <https://research.tib.eu/covid-19/entity/Nakashima_Jotaro> <https://research.tib.eu/covid-19/entity/Yasukawa_Mami>
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/cas.14618>
?:doi	10.1111/cas.14618
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Cancer science
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32805774>
?:pmid	<https://research.tib.eu/covid-19/entity/32805774>
?:pmid	32805774
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.744
?:rankingScore_hIndex	123
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1705316_TREATS_C0027651> <https://research.tib.eu/covid-19/entity/C3539125_INTERACTS_WITH_C0003451>
?:title	RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32805774>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32805774>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all